Author

Jonathan D. Lindbloom

Every paper listing this name carries an ORCID.

Identified by ORCID

Jonathan D. LindbloomiD1 paper · University College Cork

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Darren RuaneiD· 1 shared Eirini GiannoudakiiD· 1 shared Emery G. DoraiD· 1 shared Heather Loughnane· 1 shared Katherine A. Hodgson· 1 shared Larissa BlessiD· 1 shared Margaret B. LucittiD· 1 shared Molly R. BrauniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Darren RuaneORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deficiency of IL-36 receptor antagonist (DITRA) is associated with decreased homoeostatic CCL27 expression leading to heightened dermal inflammation.

Shrikanth Chomanahalli Basavarajappa, Paloma Narros‐Fernández, Heather Loughnane, Larissa Bless, Yasmina Hernandez-Santana, Eirini Giannoudaki, Anne Moore, Margaret B. Lucitt, Darren Ruane, Patrick T. Walsh

This study shows that IL-36Ra deficiency reduces CCL27 expression, leading to skin inflammation in DITRA patients and mice, and that restoring CCL27 mitigates inflammation.

bioRxiv · Jun 12, 2026 · PreprintImmunology

Elimination of human papillomavirus 16-induced tumors by a mucosal rAd5 therapeutic vaccination in a pre-clinical study

Molly R. Braun, Jonathan D. Lindbloom, Katherine A. Hodgson, Emery G. Dora, Sean N. Tucker

This study shows that mucosal rAd5 vaccines targeting HPV16 E6 and E7 proteins reduce tumor volume and improve survival in a mouse model of HPV-induced cancer.

Vaccines · Aug 23, 2024Peer-reviewedImmunology